FRDPX
Price
$97.74
Change
+$0.29 (+0.30%)
Updated
Aug 27 closing price
Net Assets
28.07B
VFIAX
Price
$601.05
Change
+$1.91 (+0.32%)
Updated
Aug 28 closing price
Net Assets
1.33T
Interact to see
Advertisement

FRDPX vs VFIAX

Header iconFRDPX vs VFIAX Comparison
Open Charts FRDPX vs VFIAXBanner chart's image
Franklin Rising Dividends A
Price$97.74
Change+$0.29 (+0.30%)
VolumeN/A
Net Assets28.07B
Vanguard 500 Index Admiral
Price$601.05
Change+$1.91 (+0.32%)
VolumeN/A
Net Assets1.33T
FRDPX vs VFIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FRDPX vs. VFIAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRDPX is a Buy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.33T vs. FRDPX (28.1B). VFIAX pays higher dividends than FRDPX: VFIAX (1.18) vs FRDPX (0.68). FRDPX was incepted earlier than VFIAX: FRDPX (39 years) vs VFIAX (25 years). FRDPX (0.84) is less costly to investors than VFIAX (0.04). FRDPX is a more actively managed with annual turnover of: 12.32 vs. VFIAX (2.00). FRDPX has a lower initial minimum investment than VFIAX: FRDPX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 15.96 vs. FRDPX (0.70). VFIAX return over 5 years is better than : 84.80 vs. FRDPX (34.78).
FRDPXVFIAXFRDPX / VFIAX
Total Expense Ratio0.830.042,075%
Annual Report Gross Expense Ratio0.840.042,100%
Fund Existence39 years25 years-
Gain YTD9.93610.41295%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets28.1B1.33T2%
Annual Yield % from dividends0.681.1857%
Returns for 1 year0.7015.964%
Returns for 3 years17.7760.8629%
Returns for 5 years34.7884.8041%
Returns for 10 years107.27228.5947%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZVRA9.30-0.06
-0.64%
Zevra Therapeutics
PMCB0.96-0.01
-1.03%
PharmaCyte Biotech
CNTB1.76-0.02
-1.12%
Connect Biopharma Holdings Limited
LU2.96-0.06
-1.99%
Lufax Holding Ltd
COO64.58-9.53
-12.85%
Cooper Companies (The)